{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:00:59Z","timestamp":1768888859092,"version":"3.49.0"},"reference-count":39,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1620\/tjem.2024.j019","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T22:11:35Z","timestamp":1708553495000},"page":"105-113","source":"Crossref","is-referenced-by-count":1,"title":["Risk of Hemorrhagic Stroke among Patients Treated with High-Intensity Statins versus Pitavastatin-Ezetimibe: A Population Based Study"],"prefix":"10.1620","volume":"263","author":[{"given":"Po-Sheng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ling","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"},{"name":"Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hsiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"},{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University"},{"name":"Department of Public Health, College of Medicine, National Cheng Kung University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Heng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Amarenco, P., Bogousslavsky, J., Callahan, A. 3rd, Goldstein, L.B., Hennerici, M., Rudolph, A.E., Sillesen, H., Simunovic, L., Szarek, M., Welch, K.M. &amp;Zivin, J.A.;Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators  (2006)  High-dose atorvastatin after stroke or transient ischemic attack.  <i>N. Engl. J. Med.<\/i>, 355, 549-559."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Catapano, A.L. (2010)  Pitavastatin - pharmacological profile from early phase studies.  <i>Atheroscler. Suppl.<\/i>, 11, 3-7.","DOI":"10.1016\/S1567-5688(10)71063-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chen, P.S., Lee, M., Tang, S.C., Huang, P.H., Yeh, H.I., Jia-Yin Hou, C., Hsieh, I.C., Lee, J.T., Jeng, J.S. &amp; Li, Y.H. (2022)  2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: coronary artery disease, peripheral artery disease and ischemic stroke.  <i>J. Formos. Med. Assoc.<\/i>, 121, 1363-1370.","DOI":"10.1016\/j.jfma.2022.03.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cheng, C.L., Lee, C.H., Chen, P.S., Li, Y.H., Lin, S.J. &amp; Yang, Y.H. (2014)  Validation of acute myocardial infarction cases in the national health insurance research database in taiwan.  <i>J. Epidemiol.<\/i>, 24, 500-507.","DOI":"10.2188\/jea.JE20140076"},{"key":"5","unstructured":"Cheng, Y., Qiao, L., Jiang, Z., Dong, X., Feng, H., Gui, Q., Lu, Y. &amp; Liang, Y. (2020)  Significant reduction in the LDL cholesterol increases the risk of intracerebral hemorrhage: a systematic review and meta-analysis of 33 randomized controlled trials.  <i>Am. J. Transl. Res.<\/i>, 12, 463-477."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT)  Collaboration;Baigent,C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., Peto, R., Barnes, E.H., Keech, A., Simes, J. &amp; Collins, R. (2010)  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.  <i>Lancet<\/i>, 376, 1670-1681.","DOI":"10.1016\/S0140-6736(10)61350-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Collins, R., Armitage, J., Parish, S., Sleight, P. &amp;Peto, R.;  Heart Protection Study Collaborative Group  (2004)  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.  <i>Lancet<\/i>, 363, 757-767.","DOI":"10.1016\/S0140-6736(04)15690-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Ference, B.A., Ginsberg, H.N., Graham, I., Ray, K.K., Packard, C.J., Bruckert, E., Hegele, R.A., Krauss, R.M., Raal, F.J., Schunkert, H., Watts, G.F., Boren, J., Fazio, S., Horton, J.D., Masana, L., et al.  (2017)  Low-density lipoproteins cause atherosclerotic cardiovascular disease.  1.  Evidence from genetic, epidemiologic, and clinical studies.  A consensus statement from the European Atherosclerosis Society Consensus Panel.  <i>Eur. Heart J.<\/i>, 38, 2459-2472.","DOI":"10.1093\/eurheartj\/ehx144"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Ference, B.A., Graham, I., Tokgozoglu, L. &amp; Catapano, A.L. (2018)  Impact of lipids on cardiovascular health: JACC health promotion series.  <i>J. Am. Coll. Cardiol.<\/i>, 72, 1141-1156.","DOI":"10.1016\/j.jacc.2018.06.046"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Giugliano, R.P., Pedersen, T.R., Saver, J.L., Sever, P.S., Keech, A.C., Bohula, E.A., Murphy, S.A., Wasserman, S.M., Honarpour, N., Wang, H., Lira Pineda, A., Sabatine, M.S. &amp; Investigators, F. (2020)  Stroke prevention with the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9)  inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis.  <i>Stroke<\/i>, 51, 1546-1554.","DOI":"10.1161\/STROKEAHA.119.027759"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Giugliano, R.P., Wiviott, S.D., Blazing, M.A., De Ferrari, G.M., Park, J.G., Murphy, S.A., White, J.A., Tershakovec, A.M., Cannon, C.P. &amp; Braunwald, E. (2017)  Long-term safety and efficacy of achieving very low levels of low-density lipoprotein cholesterol : a prespecified analysis of the IMPROVE-IT trial.  <i>JAMA Cardiol.<\/i>, 2, 547-555.","DOI":"10.1001\/jamacardio.2017.0083"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Grundy, S.M., Stone, N.J., Bailey, A.L., Beam, C., Birtcher, K.K., Blumenthal, R.S., Braun, L.T., de Ferranti, S., Faiella-Tommasino, J., Forman, D.E., Goldberg, R., Heidenreich, P.A., Hlatky, M.A., Jones, D.W., Lloyd-Jones, D., et al.  (2019)  2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.  <i>J. Am. Coll. Cardiol.<\/i>, 73, 3168-3209.","DOI":"10.1161\/CIR.0000000000000624"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hagiwara, N., Kawada-Watanabe, E., Koyanagi, R., Arashi, H., Yamaguchi, J., Nakao, K., Tobaru, T., Tanaka, H., Oka, T., Endoh, Y., Saito, K., Uchida, T., Matsui, K. &amp; Ogawa, H. (2017)  Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.  <i>Eur. Heart J.<\/i>, 38, 2264-2276.","DOI":"10.1093\/eurheartj\/ehx162"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hayashi, T., Yokote, K., Saito, Y. &amp; Iguchi, A. (2007)  Pitavastatin: efficacy and safety in intensive lipid lowering.  <i>Expert Opin. Pharmacother.<\/i>, 8, 2315-2327.","DOI":"10.1517\/14656566.8.14.2315"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hsieh, C.Y., Chen, C.H., Li, C.Y. &amp; Lai, M.L. (2015)  Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database.  <i>J. Formos. Med. Assoc.<\/i>, 114, 254-259.","DOI":"10.1016\/j.jfma.2013.09.009"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hsieh, C.Y., Su, C.C., Shao, S.C., Sung, S.F., Lin, S.J., Kao Yang, Y.H. &amp; Lai, E.C. (2019)  Taiwan\u2019s National Health Insurance Research Database: past and future.  <i>Clin. Epidemiol.<\/i>, 11, 349-358.","DOI":"10.2147\/CLEP.S196293"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hsieh, M.T., Hsieh, C.Y., Tsai, T.T., Wang, Y.C. &amp; Sung, S.F. (2020)  Performance of ICD-10-CM diagnosis codes for identifying acute ischemic stroke in a National Health Insurance claims database.  <i>Clin. Epidemiol.<\/i>, 12, 1007-1013.","DOI":"10.2147\/CLEP.S273853"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lee, M., Cheng, C.Y., Wu, Y.L., Lee, J.D., Hsu, C.Y. &amp; Ovbiagele, B. (2022)  Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention: a meta-analysis of randomized clinical trials.  <i>JAMA Neurol.<\/i>, 79, 349-358.","DOI":"10.1001\/jamaneurol.2021.5578"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lei, C., Wu, B., Liu, M. &amp; Chen, Y. (2014)  Association between statin use and intracerebral hemorrhage: a systematic review and meta-analysis.  <i>Eur. J. Neurol.<\/i>, 21, 192-198.","DOI":"10.1111\/ene.12273"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Liao, J.K. (2007)  Safety and efficacy of statins in Asians.  <i>Am. J. Cardiol.<\/i>, 99, 410-414.","DOI":"10.1016\/j.amjcard.2006.08.051"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lin, J.L., Chen, P.S., Lin, H.W., Tsai, L.M., Lin, S.H. &amp; Li, Y.H. (2022)  Real-world analyses of the safety outcome among a general population treated with statins: an Asian population-based study.  <i>J. Atheroscler. Thromb.<\/i>, 29, 1213-1225.","DOI":"10.5551\/jat.63076"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Ma, C., Gurol, M.E., Huang, Z., Lichtenstein, A.H., Wang, X., Wang, Y., Neumann, S., Wu, S. &amp; Gao, X. (2019)  Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study.  <i>Neurology<\/i>, 93, e445-e457.","DOI":"10.1212\/WNL.0000000000007853"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Mach, F., Baigent, C., Catapano, A.L., Koskinas, K.C., Casula, M., Badimon, L., Chapman, M.J., De Backer, G.G., Delgado, V., Ference, B.A., Graham, I.M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T.R., et al.  (2020)  2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.  <i>Eur. Heart J.<\/i>, 41, 111-188.","DOI":"10.15829\/1560-4071-2020-3826"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Naito, R., Miyauchi, K. &amp; Daida, H. (2017)  Racial differences in the cholesterol-lowering effect of statin.  <i>J. Atheroscler. Thromb.<\/i>, 24, 19-25.","DOI":"10.5551\/jat.RV16004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Pandit, A.K., Kumar, P., Kumar, A., Chakravarty, K., Misra, S. &amp; Prasad, K. (2016)  High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis.  <i>Acta Neurol. Scand.<\/i>, 134, 22-28.","DOI":"10.1111\/ane.12540"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Riis, A.H., Erichsen, R., Ostenfeld, E.B., H\u00f8jskov, C.S., Thorlacius-Ussing, O., Stender, M.T., Lash, T.L. &amp; M\u00f8ller, H.J. (2019)  Validating registry data on statins prescriptions by blood measurements.  <i>Pharmacoepidemiol. Drug Saf.<\/i>, 28, 609-615.","DOI":"10.1002\/pds.4700"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Sanz-Cuesta, B.E. &amp; Saver, J.L. (2021)  Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors.  <i>Stroke<\/i>, 52, 3142-3150.","DOI":"10.1161\/STROKEAHA.121.034576"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Seo, W.W., Seo, S.I., Kim, Y., Yoo, J.J., Shin, W.G., Kim, J., You, S.C., Park, R.W., Park, Y.M., Kim, K.J., Rhee, S.Y., Park, M., Jin, E.S. &amp; Kim, S.E. (2022)  Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.  <i>Cardiovasc. Diabetol.<\/i>, 21, 82.","DOI":"10.1186\/s12933-022-01524-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Shoamanesh, A. &amp; Selim, M. (2022)  Use of lipid-lowering drugs after intracerebral hemorrhage.  <i>Stroke<\/i>, 53, 2161-2170.","DOI":"10.1161\/STROKEAHA.122.036889"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sun, L., Clarke, R., Bennett, D., Guo, Y., Walters, R.G., Hill, M., Parish, S., Millwood, I.Y., Bian, Z., Chen, Y., Yu, C., Lv, J., Collins, R., Chen, J., Peto, R., et al.  (2019)  Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults.  <i>Nat. Med.<\/i>, 25, 569-574.","DOI":"10.1038\/s41591-019-0366-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Taguchi, I., Iimuro, S., Iwata, H., Takashima, H., Abe, M., Amiya, E., Ogawa, T., Ozaki, Y., Sakuma, I., Nakagawa, Y., Hibi, K., Hiro, T., Fukumoto, Y., Hokimoto, S., Miyauchi, K., et al.  (2018)  High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial.  <i>Circulation<\/i>, 137, 1997-2009.","DOI":"10.1161\/CIRCULATIONAHA.117.032615"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Takahashi, M., Tsuchida, K., Sato, Y., Iimuro, S., Kario, K., Kimura, T. &amp; Nagai, R. (2020)  High-dose statin therapy and the risk of haemorrhagic stroke in Asian patients with stable coronary artery disease: insights from the REAL-CAD study.  <i>Eur. Heart J.<\/i>, 41 (Suppl. 2), 1326.","DOI":"10.1093\/ehjci\/ehaa946.1326"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Teoh, R.J.J., Huang, C.J., Chan, C.P., Chien, L.Y., Chung, C.P., Sung, S.H., Chen, C.H., Chiang, C.E. &amp; Cheng, H.M. (2019)  Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis.  <i>Ther. Adv. Neurol. Disord.<\/i>, 12, 1756286419864830.","DOI":"10.1177\/1756286419864830"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Tsai, C.F., Thomas, B. &amp; Sudlow, C.L. (2013)  Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review.  <i>Neurology<\/i>, 81, 264-272.","DOI":"10.1212\/WNL.0b013e31829bfde3"},{"key":"35","doi-asserted-by":"crossref","unstructured":"van Asch, C.J., Luitse, M.J., Rinkel, G.J., van der Tweel, I., Algra, A. &amp; Klijn, C.J. (2010)  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.  <i>Lancet Neurol.<\/i>, 9, 167-176.","DOI":"10.1016\/S1474-4422(09)70340-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Violi, F., Calvieri, C., Ferro, D. &amp; Pignatelli, P. (2013)  Statins as antithrombotic drugs.  <i>Circulation<\/i>, 127, 251-257.","DOI":"10.1161\/CIRCULATIONAHA.112.145334"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Watanabe, E., Yamaguchi, J., Arashi, H., Ogawa, H. &amp; Hagiwara, N. (2015)  Effects of statin versus the combination of ezetimibe plus statin on serum lipid absorption markers in patients with acute coronary syndrome.  <i>J. Lipids<\/i>, 2015, 109158.","DOI":"10.1155\/2015\/109158"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yu, C.Y., Campbell, S.E., Zhu, B., Knadler, M.P., Small, D.S., Sponseller, C.A., Hunt, T.L. &amp; Morgan, R.E. (2012)  Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.  <i>Curr. Med. Res. Opin.<\/i>, 28, 187-194.","DOI":"10.1185\/03007995.2011.648264"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Ziff, O.J., Banerjee, G., Ambler, G. &amp; Werring, D.J. (2019)  Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis.  <i>J. Neurol. Neurosurg. Psychiatry<\/i>, 90, 75-83.","DOI":"10.1136\/jnnp-2018-318483"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/263\/2\/263_2024.J019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T03:43:14Z","timestamp":1719632594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/263\/2\/263_2024.J019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j019","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2024.J019"}}